Works by Scher, Howard I.

Results: 115
    1
    2
    3

    Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.

    Published in:
    AUANews, 2023, p. 12
    By:
    • Breen, Kelsey E.;
    • Symecko, Heather;
    • Spielman, Kelsey;
    • Gebert, Rebecca;
    • Shah, Ibrahim H.;
    • Pundock, Stacy;
    • Batson, Melissa;
    • Narayan, Vivek K.;
    • Stadler, Zsofia K.;
    • Autio, Karen A.;
    • Abida, Wassim;
    • Danila, Daniel C.;
    • Scher, Howard I.;
    • Morris, Michael J.;
    • Hamilton, Jada G.;
    • Robson, Mark E.;
    • Domchek, Susan M.;
    • Carlo, Maria I.
    Publication type:
    Article
    4
    5
    6

    Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 730, doi. 10.1002/cpt.1747
    By:
    • Febbo, Phillip G.;
    • Martin, Anne‐Marie;
    • Scher, Howard I.;
    • Barrett, J. Carl;
    • Beaver, Julia A.;
    • Beresford, Paul J.;
    • Blumenthal, Gideon M.;
    • Bramlett, Kelli;
    • Compton, Carolyn;
    • Dittamore, Ryan;
    • Eberhard, David A.;
    • Edelstein, Daniel;
    • Godsey, James;
    • Gruen, Andrew;
    • Hanlon, Sean E.;
    • Hicks, James;
    • Hovelson, Daniel;
    • Hullings, Melanie;
    • Johann, Donald;
    • Johnson, Justin
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Imaging metastatic castration-resistant prostate cancer patients with <sup>89</sup>Zr-DFO-MSTP2109A anti-STEAP1 antibody.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222844
    By:
    • Carrasquillo, Jorge A.;
    • Fine, Bernard M.;
    • Pandit-Taskar, Neeta;
    • Larson, Steven M.;
    • Fleming, Stephen E.;
    • Fox, Josef J.;
    • Cheal, Sarah M.;
    • O'Donoghue, Joseph A.;
    • Ruan, Shutian;
    • Ragupathi, Govind;
    • Lyashchenko, Serge K.;
    • Humm, John;
    • Scher, Howard I.;
    • Gönen, Mithat;
    • Williams, Simon P.;
    • Danila, Daniel C.;
    • Morris, Michael J.
    Publication type:
    Article
    18

    Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 11, p. 1517, doi. 10.2967/jnumed.118.222844
    By:
    • Carrasquillo, Jorge A.;
    • Fine, Bernard M.;
    • Pandit-Taskar, Neeta;
    • Larson, Steven M.;
    • Fleming, Stephen E.;
    • Fox, Josef J.;
    • Cheal, Sarah M.;
    • O'Donoghue, Joseph A.;
    • Ruan, Shutian;
    • Ragupathi, Govind;
    • Lyashchenko, Serge K.;
    • Humm, John L.;
    • Scher, Howard I.;
    • Gönen, Mithat;
    • Williams, Simon P.;
    • Danila, Daniel C.;
    • Morris, Michael J.
    Publication type:
    Article
    19

    First-in-Human Imaging with <sup>89</sup>Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1858, doi. 10.2967/jnumed.116.176206
    By:
    • Pandit-Taskar, Neeta;
    • O'Donoghue, Joseph A.;
    • Ruan, Shutian;
    • Lyashchenko, Serge K.;
    • Carrasquillo, Jorge A.;
    • Heller, Glenn;
    • Martinez, Danny F.;
    • Cheal, Sarah M.;
    • Lewis, Jason S.;
    • Fleisher, Martin;
    • Keppler, Jennifer S.;
    • Reiter, Robert E.;
    • Wu, Anna M.;
    • Weber, Wolfgang A.;
    • Scher, Howard I.;
    • Larson, Steven M.;
    • Morris, Michael J.
    Publication type:
    Article
    20
    21
    22

    Pharmacokinetic Assessment of the Uptake of 16β-<sup>18</sup>F-Fluoro-5α-Dihydrotestosterone (FDHT) in Prostate Tumors as Measured by PET.

    Published in:
    Journal of Nuclear Medicine, 2010, v. 51, n. 2, p. 183, doi. 10.2967/jnumed.109.066159
    By:
    • Beattie, Bradley J.;
    • Smith-Jones, Peter M.;
    • Jhanwar, Yuliya S.;
    • Schöder, Heiko;
    • Schmidtlein, C. Ross;
    • Morris, Michael J.;
    • Zanzonico, Pat;
    • Squire, Olivia;
    • Meirelles, Gustavo S. P.;
    • Finn, Ron;
    • Namavari, Mohammad;
    • Cai, Shangde;
    • Scher, Howard I.;
    • Larson, Steven M.;
    • Humm, John L.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 11, p. 1993, doi. 10.1515/cclm-2011-0967
    By:
    • Ulmert, David;
    • Vickers, Andrew J.;
    • Scher, Howard I.;
    • Becker, Charlotte;
    • Iversen, Peter;
    • Frankel, David;
    • Jensen, Jens-Kristian;
    • Olesen, Tine Kold;
    • Lilja, Hans
    Publication type:
    Article
    29

    β4 Integrin signaling induces expansion of prostate tumor progenitors.

    Published in:
    2013
    By:
    • Yoshioka, Toshiaki;
    • Otero, Javier;
    • Chen, Yu;
    • Kim, Young-Mi;
    • Koutcher, Jason A;
    • Satagopan, Jaya;
    • Reuter, Victor;
    • Carver, Brett;
    • de Stanchina, Elisa;
    • Enomoto, Katsuhiko;
    • Greenberg, Norman M;
    • Scardino, Peter T;
    • Scher, Howard I;
    • Sawyers, Charles L;
    • Giancotti, Filippo G
    Publication type:
    journal article
    30

    ß4 Integrin signaling induces expansion of prostate tumor progenitors.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 2, p. 682, doi. 10.1172/JCI60720
    By:
    • Yoshioka, Toshiaki;
    • Otero, Javier;
    • Yu Chen;
    • Kim, Young-Mi;
    • Koutcher, Jason A.;
    • Satagopan, Jaya;
    • Reuter, Victor;
    • Carver, Brett;
    • Stanchina, Elisa de;
    • Enomoto, Katsuhiko;
    • Greenberg, Norman M.;
    • Scardino, Peter T.;
    • Scher, Howard I.;
    • Sawyers, Charles L.;
    • Giancotti, Filippo G.
    Publication type:
    Article
    31
    32

    Improved prediction of prostate cancer recurrence through systems pathology.

    Published in:
    Journal of Clinical Investigation, 2007, v. 117, p. 1876, doi. 10.1172/JCI31399
    By:
    • Cordon-Cardo, Carlos;
    • Kotsianti, Angeliki;
    • Verbel, David A.;
    • Teverovskiy, Mikhail;
    • Capodieci, Paola;
    • Hamann, Stefan;
    • Jeffers, Yusuf;
    • Clayton, Mark;
    • Elkhettabi, Faysal;
    • Khan, Faisal M.;
    • Sapir, Marina;
    • Bayer-Zubek, Valentina;
    • Vengrenyuk, Yevgen;
    • Fogarsi, Stephen;
    • Saidi, Olivier;
    • Reuter, Victor E.;
    • Scher, Howard I.;
    • Kattan, Michael W.;
    • Bianco Jr., Fernando J.;
    • Wheeler, Thomas M.
    Publication type:
    Article
    33

    Improved prediction of prostate cancer recurrence through systems pathology.

    Published in:
    Journal of Clinical Investigation, 2007, v. 117, n. 7, p. 1876, doi. 10.1172/JCI31399
    By:
    • Cordon-Cardo, Carlos;
    • Kotsianti, Angeliki;
    • Verbel, David A.;
    • Teverovskiy, Mikhail;
    • Capodieci, Paola;
    • Hamann, Stefan;
    • Jeffers, Yusuf;
    • Clayton, Mark;
    • Elkhettabi, Faysal;
    • Khan, Faisal M.;
    • Sapir, Marina;
    • Bayer-Zubek, Valentina;
    • Vengrenyuk, Yevgen;
    • Fogarsi, Stephen;
    • Saidi, Olivier;
    • Reuter, Victor E.;
    • Scher, Howard I.;
    • Kattan, Michael W.;
    • Bianco Jr., Fernando J.;
    • Wheeler, Thomas M.
    Publication type:
    Article
    34
    35

    Workgroup 3: Transgenic and reconstitution models of prostate cancer.

    Published in:
    Prostate, 1998, v. 36, n. 1, p. 59, doi. 10.1002/(SICI)1097-0045(19980615)36:1&lt;59::AID-PROS11&gt;3.0.CO;2-H
    By:
    • Green, Jeffrey E.;
    • Greenberg, Norman M.;
    • Ashendel, Curtis L.;
    • Barrett, J. Carl;
    • Boone, Charles;
    • Getzenberg, Robert H.;
    • Henkin, Jack;
    • Matusik, Robert;
    • Janus, Todd J.;
    • Scher, Howard I.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Phase I pharmacokinetic and biodistribution study with escalating doses of <sup>223</sup>Ra-dichloride in men with castration-resistant metastatic prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 9, p. 1384, doi. 10.1007/s00259-013-2427-6
    By:
    • Carrasquillo, Jorge A.;
    • O’Donoghue, Joseph A.;
    • Pandit-Taskar, Neeta;
    • Humm, John L.;
    • Rathkopf, Dana E.;
    • Slovin, Susan F.;
    • Williamson, Matthew J.;
    • Lacuna, Kristine;
    • Aksnes, Anne-Kirsti;
    • Larson, Steven M.;
    • Scher, Howard I.;
    • Morris, Michael J.
    Publication type:
    Article
    42

    Identification of novel androgen receptor target genes in prostate cancer.

    Published in:
    Molecular Cancer, 2007, v. 6, p. 39, doi. 10.1186/1476-4598-6-39
    By:
    • Jariwala, Unnati;
    • Prescott, Jennifer;
    • Li Jia;
    • Barski, Artem;
    • Pregizer, Steve;
    • Cogan, Jon P.;
    • Arasheben, Armin;
    • Tilley, Wayne D.;
    • Scher, Howard I.;
    • Gerald, William L.;
    • Buchanan, Grant;
    • Coetzee, Gerhard A.;
    • Frenkel, Baruch
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50